The Latest Breaking News from GSK

Of the most senior full time jobs on the career ladder to chief executive, such as divisional or regional heads, only 21% are held by women.

GSK stock plunged Wednesday after sales of its RSV vaccine, Arexvy, skidded and widely missed Wall Street's expectations.

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the Federal Reserve's November meeting.

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

CVS just announced it was considering a breakup. Why is that important? Spinoffs are one of the best-kept investment secrets, despite the fact that many investors typically disregard them and frequently outperform more general markets.

About 6,000 to 10,000 people 65 and older die from RSV in the U.S. annually, the CDC says.

We can likely expect a short trip.

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.